| 前收市價 | 2.4000 |
| 開市 | 2.4000 |
| 買盤 | 0.0000 |
| 賣出價 | 3.6000 |
| 拍板 | 4.00 |
| 到期日 | 2026-01-16 |
| 今日波幅 | 2.4000 - 2.4000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 856 |
Insider MonkeyPacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript May 9, 2024 Pacific Biosciences of California, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the PacBio First Quarter 2024 Earnings Conference Call. All […]
ZacksPacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
ZacksPacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
